Cargando…

Severity of COVID-19 cases in the months of predominance of the Alpha and Delta variants

New SARS-CoV-2 may pose problems in controlling the COVID-19 pandemic for public health. We aimed to assess and compare the symptoms and severity of cases due to the Alpha and Delta variant dominance periods, taking into account the effect of COVID-19 vaccination. A prospective epidemiological study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Florensa, D., Mateo, J., Spaimoc, R., Miret, C., Godoy, S., Solsona, F., Godoy, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472714/ https://www.ncbi.nlm.nih.gov/pubmed/36104358 http://dx.doi.org/10.1038/s41598-022-19125-4

Ejemplares similares

Exploring Cancer Incidence, Risk Factors, and Mortality in the Lleida Region: Interactive, Open-source R Shiny Application for Cancer Data Analysis
por: Florensa, Didac, et al.
Publicado: (2023)

Use of Multiple Correspondence Analysis and K-means to Explore Associations Between Risk Factors and Likelihood of Colorectal Cancer: Cross-sectional Study
por: Florensa, Dídac, et al.
Publicado: (2022)

Acetylsalicylic Acid Effect in Colorectal Cancer Taking into Account the Role of Tobacco, Alcohol and Excess Weight
por: Florensa, Didac, et al.
Publicado: (2023)

COVID-19 disease severity in US Veterans infected during Omicron and Delta variant predominant periods
por: Mayr, Florian B., et al.
Publicado: (2022)

Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants
por: Eyre, David W., et al.
Publicado: (2022)

Incidence and severity of pulmonary embolism in COVID-19 infection: Ancestral, Alpha, Delta, and Omicron variants
por: Wada, Noriaki, et al.
Publicado: (2023)

Predominance of delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021
por: Thangaraj, Jeromie Wesley Vivian, et al.
Publicado: (2022)

COVID-19: risk factors for severe cases of the Delta variant
por: Hu, Kaiyuan, et al.
Publicado: (2021)

Severe COVID-19 outcomes in pediatrics: an observational cohort analysis comparing Alpha, Delta, and Omicron variants
por: Bahl, Amit, et al.
Publicado: (2022)

Continued effectiveness of COVID-19 vaccination among urban healthcare workers during delta variant predominance
por: Lan, Fan-Yun, et al.
Publicado: (2022)

COVID-19 long-term sequelae: Omicron versus Alpha and Delta variants
por: Hernández-Aceituno, Ana, et al.
Publicado: (2023)

Changes in infectivity, severity and vaccine effectiveness against delta COVID-19 variant ten months into the vaccination program: The Israeli case
por: Saban, Mor, et al.
Publicado: (2022)

Severe Breakthrough COVID-19 Cases during Six Months of Delta Variant (B.1.617.2) Domination in Poland
por: Rzymski, Piotr, et al.
Publicado: (2022)

Comparison of clinical characteristics of COVID-19 in pregnant women between the Delta and Omicron variants of concern predominant periods
por: Shoji, Kensuke, et al.
Publicado: (2023)

Comparative severity of COVID-19 cases caused by Alpha, Delta or Omicron SARS-CoV-2 variants and its association with vaccination
por: Varea-Jiménez, Elena, et al.
Publicado: (2022)

Comparative severity of COVID-19 cases caused by Alpha, Delta or Omicron SARS-CoV-2 variants and its association with vaccination
por: Varea-Jiménez, Elena, et al.
Publicado: (2023)

COVID-19 vaccination coverage and associated factors in seasonal fruit workers in Lleida
por: Miret, Carme, et al.
Publicado: (2022)

COVID-19 vaccination coverage and associated factors in seasonal fruit workers in Lleida
por: Miret, Carme, et al.
Publicado: (2022)

Estimation of the basic reproduction number of Alpha and Delta variants of COVID-19 pandemic in Iran
por: Sheikhi, Farnaz, et al.
Publicado: (2022)

Humoral Response in Hemodialysis Patients Following COVID-19 Vaccination and Breakthrough Infections during Delta and Omicron Variant Predominance
por: Chinnadurai, Rajkumar, et al.
Publicado: (2022)

Use of the Monoclonal Antibody Regdanvimab to Treat Patients Hospitalized with COVID-19: Real-World Data during the Delta Variant Predominance
por: Kwak, Yee Gyung, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Replacement of Delta as Predominant Variant, Puerto Rico
por: Santiago, Gilberto A., et al.
Publicado: (2023)

Effectiveness of Monoclonal Antibodies in Preventing Severe COVID-19 With Emergence of the Delta Variant
por: O’Horo, John C., et al.
Publicado: (2022)

The disease burden of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort
por: Sendi, Parham, et al.
Publicado: (2022)

HETEROLOGOUS THIRD AND FOURTH DOSE VACCINE TO REDUCE SEVERITY AND MORTALITY IN COVID-19 PATIENTS DURING DELTA AND OMICRON PREDOMINANT IN THAILAND
por: Chariyalertsak, S., et al.
Publicado: (2023)

2294. Severity and characteristics of patients hospitalized during Delta and Omicron-predominant COVID-19 time periods in Los Angeles County
por: Greene, Carmon, et al.
Publicado: (2023)

Time series forecasting of COVID-19 infections and deaths in Alpha and Delta variants using LSTM networks
por: Sheikhi, Farnaz, et al.
Publicado: (2023)

COVID-19 disease severity in persons infected with the Omicron variant compared with the Delta variant in Qatar
por: Butt, Adeel A, et al.
Publicado: (2022)

Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study
por: Fabiani, Massimo, et al.
Publicado: (2022)

Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States
por: Schrag, Stephanie J., et al.
Publicado: (2022)

The Impact of SARS-CoV-2 Primary Vaccination in a Cohort of Patients Hospitalized for Acute COVID-19 during Delta Variant Predominance
por: Stupica, Daša, et al.
Publicado: (2022)

Multimorbidity and Frailty Are the Key Characteristics of Patients Hospitalized with COVID-19 Breakthrough Infection during Delta Variant Predominance in Italy: A Retrospective Study
por: Ticinesi, Andrea, et al.
Publicado: (2022)

Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 – February 2022)
por: Petrone, Daniele, et al.
Publicado: (2023)

COVID-19 vaccines in the age of the delta variant
por: Wheatley, Adam K, et al.
Publicado: (2022)

Delta Variant of Covid-19 and Hearing Loss
por: Umashankar, Abishek, et al.
Publicado: (2023)

Mesenteric Infarction With Cerebral Thrombotic Relapses and Pulmonary Embolism Two and Four Months After COVID-19
por: Pereira de Godoy, Henrique Jose, et al.
Publicado: (2023)

COVID‐19 severity from Omicron and Delta SARS‐CoV‐2 variants
por: Wrenn, Jesse O., et al.
Publicado: (2022)

Reduction in severity and mortality in COVID-19 patients owing to heterologous third and fourth-dose vaccines during the periods of delta and omicron predominance in Thailand
por: Intawong, Kannikar, et al.
Publicado: (2023)

Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence
por: Puranik, Arjun, et al.
Publicado: (2021)

Rates Of Corticosteroid And Antibiotic Prescriptions Are Significantly Increased With Omicron As Compared To Alpha And Delta Variants Of COVID-19 In Patients With Asthma
por: Kudlaty, Elizabeth, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_13f7mt6dg3uisb22r7hesm6e6f